Early-life differences in the gut microbiota composition and functionality of infants at elevated likelihood of developing autism spectrum disorder
Year: 2023
Type: article
Study design: Observational Study
Abstract: Evidence from cross-sectional human studies, and preliminary microbial-based intervention studies, have implicated the microbiota-gut-brain axis in the neurobiology of autism spectrum disorder (ASD). Using a prospective longitudinal study design, we investigated the developmental profile of the fecal microbiota and metabolome in infants with (n = 16) and without (n = 19) a family history of ASD across the first 36 months of life. In addition, the general developmental levels of infants were evaluated using the Mullen Scales of Early Learning (MSEL) test at 5 and 36 months of age, and with ADOS-2 at 36 months of age. At 5 months of age, infants at elevated-likelihood of ASD (EL) harbored less Bifidobacterium and more Clostridium and Klebsiella species compared to the low-likelihood infants (LL). Untargeted metabolic profiling highlighted that LL infants excreted a greater amount of fecal γ-aminobutyric acid (GABA) at 5 months, which progressively declined with age. Similar age-dependent patterns were not observed in the EL group, with GABA being consistently low across all timepoints. Integrated microbiome-metabolome analysis showed a positive correlation between GABA and Bifidobacterium species and negative associations with Clostridium species. In vitro experiments supported these observations demonstrating that bifidobacteria can produce GABA while clostridia can consume it. At the behavioral level, there were no significant differences between the EL and LL groups at 5 months. However, at 36 months of age, the EL group had significantly lower MSEL and ADOS-2 scores compared to the LL group. Taken together, the present results reveal early life alterations in gut microbiota composition and functionality in infants at elevated-likelihood of ASD. These changes occur before any behavioral impairments can be detected, supporting a possible role for the gut microbiota in emerging behavioral variability later in life.
Source: Translational Psychiatry
Authors: Simone Zuffa, Patrick Schimmel, Ayoze Gonzalez-Santana, Clara Belzer, Jan Knol, Sven Bölte, Terje Falck-Ytter, Hans Forssberg, Jonathan Swann, Rochellys Diaz Heijtz
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,790
Funders: National Institute for Health and Care Research, Research Councils UK, Hjärnfonden, Karolinska Institutet, Vetenskapsrådet, Svenska Frimurarorden, National Institute for Health Research Southampton Biomedical Research Centre, Medical Research Council, Biotechnology and Biological Sciences Research Council
Awards: G1090797732, G1573288915, G196680313, The role of gut microbiota in typical and atypical brain development, G3652238511, Do systemic metabolites drive the chondroprotective effects of the IL18-/- gut microbiome in osteoarthritis?, G5461265092, Investigating the influence of gut microbial metabolism on normal age-related cognitive decline, The effect of early-life prebiotic feeding on adult hippocampal function, central and peripheral metabonomics and microbial metagenomics, G8562758266
OpenAlex ID: W37443359
